Newer drugs to reduce high blood pressure better than standard treatments

September 04, 2005

A combination of modern anti-hypertensive drugs can reduce a patient's risk of stroke and heart attack to a greater extent than standard treatments, conclude the results of a randomised trial published online today by THE LANCET.

Hypertension is the most important preventable cause of premature death in developed countries, and the benefits of antihypertensive drugs for prevention of cardiovascular mortality and morbidity are well established. However, no individual trial using standard diuretic or ß-blocker therapy, or both has shown a significant reduction in coronary heart disease. Previous studies have suggested that newer agents would confer advantages over diuretics and ß-blockers.

In the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT), Bjorn Dahlof (Sahlgrenska University Hospital, Sweden) and colleagues compared the effect of combinations of older drugs--atenolol and thiazide--with newer drugs, amlodipine and perindopril. The investigators recruited 19, 257 patients aged between 40-79 years who had a least three other risk factors for cardiovascular events. Half of the patients were assigned the atenolol-based regimen and half the amlodipine-based regimen. After 5 years the investigators found those allocated the amlodipine-based regimen had lower blood pressure values than those on the atenolol -based regimen. They also found that the newer drugs prevented more major cardiovascular events and caused fewer cases of diabetes than the older drugs.

Dr Dahlof comments: "The preferential reduction in cardiovascular events associated with an antihypertensive regimen of a calcium-channel blocker (amlodipine) with addition of perindopril if necessary, particularly when used in combination with effective lipid lowering, results in the prevention of most major cardiovascular events associated with hypertension. We hope these results will be used to inform clinical practice in ways that should greatly reduce the burden of cardiovascular disease to which patients with hypertension are exposed."

In a second study Neil Poulter (Imperial College London, UK) and colleagues looked at differences in blood pressure and other variables in patients assigned the newer drugs versus those allocated the standard drugs. They found that a reduction in blood pressure was the single biggest contributor to the effect on stroke events, but other factors, such as differences in cholesterol, were more important for coronary events.

In an accompanying comment Jan Staessen (University of Leuven, Belgium) states: "On balance, the ASCOT results endorse the European guidelines for the treatment of hypertension, which leave the responsibility to choose the drug class to initiate antihypertensive to the doctor. ASCOT also supports the use of newer drugs, especially in patients with complicated hypertension, associated risk factors and/or metabolic disturbances...Governments and health care insurers will have to accept that the use of antihypertensive drugs cannot be rationed."
-end-
Contact: Mike Gibbs T) 44-787-981-3667 ; mgibbs@sherbornegibbs.co.uk
Alex Greathead T) 44-776-673-6666; agreathead@sherbornegibbs.co.uk

Alison Davies T) 44-770-942-4240; adavies@sherbornegibbs.co.uk

Comment: Dr Jan A Staessen, Studiecoördinatiecentrum, Laboratorium Hypertensie, Campus Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium. T) 32-16-347-104 Jan.Staessen@med.kuleuven.ac.be

Notes to editors The results of ASCOT are being presented at the European Society of Cardiology Congress 2005 in Stockholm on Sunday, September 4.

Lancet

Related Blood Pressure Articles from Brightsurf:

Children who take steroids at increased risk for diabetes, high blood pressure, blood clots
Children who take oral steroids to treat asthma or autoimmune diseases have an increased risk of diabetes, high blood pressure, and blood clots, according to Rutgers researchers.

High blood pressure treatment linked to less risk for drop in blood pressure upon standing
Treatment to lower blood pressure did not increase and may decrease the risk of extreme drops in blood pressure upon standing from a sitting position.

Changes in blood pressure control over 2 decades among US adults with high blood pressure
National survey data were used to examine how blood pressure control changed overall among U.S. adults with high blood pressure between 1999-2000 and 2017-2018 and by age, race, insurance type and access to health care.

Transient increase in blood pressure promotes some blood vessel growth
Blood vessels are the body's transportation system, carrying oxygen and nutrients to cells and whisking away waste.

Effect of reducing blood pressure medications on blood pressure control in older adults
Whether the amount of blood pressure medications taken by older adults could be reduced safely and without a significant change in short-term blood pressure control was the objective of this randomized clinical trial that included 534 adults 80 and older.

Brain blood flow sensor discovery could aid treatments for high blood pressure & dementia
A study led by researchers at UCL has discovered the mechanism that allows the brain to monitor its own blood supply, a finding in rats which may help to find new treatments for human conditions including hypertension (high blood pressure) and dementia.

Here's something that will raise your blood pressure
The apelin receptor (APJ) has been presumed to play an important role in the contraction of blood vessels involved in blood pressure regulation.

New strategy for treating high blood pressure
The key to treating blood pressure might lie in people who are 'resistant' to developing high blood pressure even when they eat high salt diets, shows new research published today in Experimental Physiology.

Arm cuff blood pressure measurements may fall short for predicting heart disease risk in some people with resistant high blood pressure
A measurement of central blood pressure in people with difficult-to-treat high blood pressure could help reduce risk of heart disease better than traditional arm cuff readings for some patients, according to preliminary research presented at the American Heart Association's Hypertension 2019 Scientific Sessions.

Heating pads may lower blood pressure in people with high blood pressure when lying down
In people with supine hypertension due to autonomic failure, a condition that increases blood pressure when lying down, overnight heat therapy significantly decreased systolic blood pressure compared to a placebo.

Read More: Blood Pressure News and Blood Pressure Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.